Venture Capital & Emerging Companies
Viewpoints
Filter by:
New for 2024: Compliance with the Corporate Transparency Act Necessary for Many Mintz Clients
February 1, 2024 | Alert | By Will Perkins, Steve Ganis, Daniel Gaquin, Daniel Guggenheim, David Adams
Reporting requirements under the Corporate Transparency Act (CTA) are in effect beginning January 1, 2024. Under the CTA, many US entities will be required to provide the personal information of their beneficial owners to the Financial Crimes Enforcement Network (FinCEN), a division of the US Treasury Department.
Section 409A Valuations: Mastering the Art and Science in a Volatile Venture Market
January 23, 2024 | Article | By Dinesh Melwani, Roman M. Gorokhov
In this article, we explore the intricacies of 409A valuations, focusing on their importance, timing, and methodologies, and offer strategies for challenging valuations — assuming reliance on third-party assessments.
Client Corner: Gio Traverso’s Journey Starting Biotech Companies
January 12, 2024 | Podcast | By Joshua D. Fox
In this episode of Client Corner, Josh speaks to Gio Traverso, MIT professor, founder of several biotech companies, and a physician. Gio discusses his experience starting six different companies with Josh, comprising both for-profit and nonprofit entities. He reflects upon the process of deciding whether to start a business using a nonprofit or a for-profit structure, bringing together a strong team, evaluating potential investors, and licensing intellectual property from a university.
Client Corner: Carlos Araque on Leading a Startup
December 15, 2023 | Podcast | By Joshua D. Fox
In this week’s episode of Client Corner, Josh speaks to Carlos Araque, Co-founder and CEO of Quaise Energy. Carlos discusses his motivation in developing Quaise Energy and his guiding philosophy of impact over probability of success. He provides advice to other first-time CEOs and offers insights on the state of diversity in the technology sector.
MintzTech Connect Client Spotlight: Moolah Kicks Founder Natalie White Recognized as a “30 Under 30” by Forbes
December 15, 2023 | Article | By Daniel DeWolf, Samuel Asher Effron
As reported in Forbes, Natalie White was recognized as a “30 under 30” for Sports. Natalie founded Moolah Kicks, the first basketball shoe brand focused solely on women.
MintzTech Connect: All Things Technology — December 2023
December 15, 2023 | Article | By Daniel DeWolf, Samuel Asher Effron
This issue of MintzTech Connect covers a Globe and Mail piece on Mintz’s continued expansion in Toronto, Biden’s executive order on artificial intelligence, Forbes magazine’s recognition of Moolah Kicks founder Natalie White’s inclusion on its “30 Under 30” list, and our Client Corner podcast featuring a conversation with NextGen Jane Co-founder & CEO Ridhi Tariyal.
Client Corner: Anna Turetsky on Venture Investing
December 1, 2023 | Podcast | By Joshua D. Fox
In this week’s episode of Client Corner, Member and Host Josh Fox chats with Anna Turetsky, Principal, Venture Investments for the Mark Foundation for Cancer Research.
Client Corner: Meet Syntis Bio Co-founder and CEO Rahul Dhanda
November 10, 2023 | Podcast | By Joshua D. Fox
In this episode of Client Corner, Josh chats with Rahul Dhanda, co-founder and CEO of Syntis Bio, a late-stage, preclinical company developing a new class of therapy.
Client Corner: Meet Biotech Executive John Edwards
October 27, 2023 | Podcast | By Joshua D. Fox
In this episode of Client Corner, Josh chats with John Edwards, an executive chair, board member, and senior adviser to start-up and clinical-stage biotechnology companies.
Client Corner: Ridhi Tariyal, Co-founder & CEO of NextGen Jane
October 13, 2023 | Podcast | By Joshua D. Fox
In this episode of Client Corner, Member Josh Fox talks with NextGen Jane’s Co-founder and CEO, Ridhi Tariyal about how the company is using precision medicine to transform obstetric and gynecological care.
Client Corner: Jerry Williamson, CEO of Sengenics
September 29, 2023 | Podcast | By Joshua D. Fox
In this episode of Client Corner, Joshua Fox chats with Jerry Williamson, CEO of Sengenics. Jerry has more than 30 years of experience in bioscience markets for life science research, diagnostics, and analytical products.
MintzTech Connect: All Things Technology — September 2023
September 12, 2023 | Article | By Daniel DeWolf, Samuel Asher Effron
This issue of MintzTech Connect covers QSBS issues related to converting an LLC into a corporation, legal decisions regarding cryptocurrencies and whether they are subject to SEC regulation, how Mintz’s partnership with Antler led to our work for oral health innovator peri, and a spotlight on mePrism, a tech company that helps customers remove their personal information from the internet.
Mintz and Antler: A Game-Changing Partnership Boosting Legal Support for Startups Everywhere — Including Innovative Health Care Company “peri”
September 12, 2023 | Article | By Stephen Osborn
Read about how Mintz’s partnership with startup accelerator and venture capital firm Antler led to Mintz’s work for oral health innovator peri.
MintzTech Connect Industry News: Spotlight on mePrism
September 12, 2023 | Article | By Samuel Asher Effron
Read about mePrism, a technology company that helps customers remove their personal information from the internet.
Considering Converting an LLC into a Corporation? Here Are the QSBS Issues You Should Be Thinking About
August 22, 2023 | Alert | By Gregg M. Benson, Daniel DeWolf, David Salamon
Read about the benefits and risks of deferring the conversion of an LLC into a corporation in order to benefit from the qualified small business stock (QSBS) rules of the US tax code.
Mintz Venture Watch — Volume 5: A Report on Deal Trends from Q1 and Q2 2023
August 21, 2023 | Article | By Daniel DeWolf, Lewis Geffen, Jeremy Glaser
Despite choppy market conditions for private companies, the Mintz Venture Capital & Emerging Companies team remained busy advising emerging companies of all sizes and at all stages of growth across a wide range of industries. For the first half of 2023 we completed 72 transactions, with an aggregate deal value in excess of $1.6 billion. Below are a few highlighted transactions:
Judge Rakoff puts the Ripple Party on Ice as the Crypto Community and SEC Ponder their Next Moves
August 7, 2023 | Blog | By Cory S. Flashner, David Adams, Edmund P. Daley, Patrick E. McDonough
Just barely two weeks ago, we wrote about the half-victory for Ripple Labs in its ongoing litigation with the Securities and Exchange Commission (“SEC”), in which Judge Analisa Torres granted partial summary judgment in favor of Ripple on the issue of whether certain sales of Ripple’s XRP cryptocurrency tokens were “securities” under the federal securities laws. Some in the crypto industry interpreted her ruling to mean that secondary transactions in crypto assets on centralized and decentralized crypto exchanges were not transactions in “securities,” even though Judge Torres expressly declined to address the secondary trading issue. Fast forward to today, and a new ruling out of the SDNY against Terraform Labs casts further doubt on this interpretation.
Five Ways To Target Success As A Startup
July 11, 2023 | Article
Turning innovation into a successful business can be daunting. In a panel discussion at the BIO International Convention, Mintz’s Josh Fox, who is a Member in our Chambers-ranked Life Sciences practice, alongside Massachusetts Institute of Technology (MIT) professors Robert Langer, Angela Koehler, and Giovanni Traverso, examined the challenges associated with spinning out innovations from academic and research institutions, including how to build a team to run a new company and how to fund startups, particularly those that may not attract traditional venture capital easily (or at all). Here are their five key takeaways.
Cross-border Considerations for the Life Sciences Industry
June 27, 2023 | Blog
Mintz welcomed investors and entrepreneurs from the Canadian and US life sciences ecosystem to our first annual matchmaking event in Toronto. In this video, hear about cross-border considerations for the sector and how Mintz’s life sciences focus positions us to guide emerging growth companies and investors doing business in both countries.
MintzTech Connect Industry News: Spotlight on Coefficient
May 24, 2023 | Article | By Daniel DeWolf
Coefficient is a B2B SaaS platform that enables users to improve business insights and increase productivity for operations, analyst and finance professionals at enterprises of all sizes. Founded in 2019 and based in San Francisco, Coefficient recently raised $18 million in a Series A financing round from Battery Ventures, S28 Capital and Foundation Capital to grow its platform.
Explore Other Viewpoints:
- AI: The Washington Report
- Antitrust
- Appellate
- Arbitration, Mediation & Alternate Dispute Resolution
- Artificial Intelligence
- Awards
- Bankruptcy & Restructuring
- California Land Use
- Cannabis
- Class Action
- Complex Commercial Litigation
- Construction
- Consumer Product Safety
- Corporate Governance (ESG)
- Cross-Border Asset Recovery
- Debt Financing
- Direct Investing (M&A)
- Diversity
- EB-5 Financing
- Education & Nonprofits
- Employment
- Energy & Sustainability
- Environmental (ESG)
- Environmental Enforcement Defense
- Environmental Law
- Environmental, Social, and Corporate Governance (ESG)
- FDA Regulatory
- False Claims Act
- Federal Circuit Appeals
- Financial Institution Litigation
- Government Law
- Growth Equity
- Health Care
- Health Care Compliance, Fraud and Abuse, & Regulatory Counseling
- Health Care Enforcement & Investigations
- Health Care Transactions
- Health Information Privacy & Security
- IP Due Diligence
- IPRs & Other Post Grant Proceedings
- Immigration
- Impacts of a New US Administration
- Insolvency & Creditor Rights Litigation
- Institutional Investor Class Action Recovery
- Insurance & Financial Services
- Insurance Consulting & Risk Management
- Insurance and Reinsurance Problem-Solving & Dispute Resolution
- Intellectual Property
- Investment Funds
- Israel
- Licensing & Technology Transactions
- Life Sciences
- Litigation & Investigations
- M&A Litigation
- ML Strategies
- Medicare, Medicaid and Commercial Coverage & Reimbursement
- Mergers & Acquisitions
- Patent Litigation
- Patent Prosecution & Strategic Counseling
- Pharmacy Benefits and PBM Contracting
- Portfolio Companies
- Privacy & Cybersecurity
- Private Client
- Private Equity
- Pro Bono
- Probate & Fiduciary Litigation
- Products Liability & Complex Tort
- Projects & Infrastructure
- Public Finance
- Real Estate Litigation
- Real Estate Transactions
- Real Estate, Construction & Infrastructure
- Retail & Consumer Products
- Securities & Capital Markets
- Securities Litigation
- Social (ESG)
- Special Purpose Acquisition Company (SPACs)
- Sports & Entertainment
- State Attorneys General
- Strategic IP Monetization & Licensing
- Tax
- Technology
- Technology, Communications & Media
- Technology, Communications & Media Litigation
- Trade Secrets
- Trademark & Copyright
- Trademark Litigation
- Value-Based Care
- Venture Capital & Emerging Companies
- White Collar Defense & Government Investigations
- Women's Health and Technology